Neurocrine Biosciences Inc NBIX:NASDAQ

Last Price$107.26Cboe Real-Time Last Sale as of 3:52PM ET 8/15/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+1.63(1.54%)
Bid (Size)$107.13 (100)
Ask (Size)$107.25 (100)
Day Low / High$105.39 - 107.45
Volume513.1 K

Neurocrine Biosciences Gets FDA's Orphan Drug Designation for Experimental Huntington Disease Drug

3:42AM ET 5/13/2022 MT Newswires
Neurocrine Biosciences (NBIX) said late Thursday the US Food and Drug Administration granted an orphan drug designation to valbenazine for the potential reduction of chorea, or movement disorder, in Huntington disease patients.

The drugmaker is currently enrolling patients in its phase 3 Kinect-HD2 study to evaluate the long-term safety and tolerability of valbenazine.